Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
19 April 2024
Dear Shareholder
ASTRAL RESOURCES NL – NOTICE OF GENERAL MEETING
Astral Resources NL (ASX: AAR) (the Company) advises that a General Meeting of Shareholders
(Meeting) will be held on Monday, 20 May 2024 at 10.00am (AWST) at the Conference Centre, Ground
Floor, Central Park Tower, 152-158 St Georges Terrace, Perth Western Australia 6000.
In accordance with 110D of the Corporations Act 2001 (Cth), the Company will not be dispatching
physical copies of the Notice of Meeting (unless a shareholder has elected to receive documents in
hard copy in accordance with the timeframe specified in section 110E(8) of the Corporations Act 2001
(Cth)).
A copy of the Meeting materials can be viewed and downloaded online as follows:
(a) You can access the Meeting materials
www.astralresources.com/asx-announcements/
online
at
the
Company’s
website:
(b) A complete copy of the Meeting materials has been posted to the Company’s ASX Market
announcements page at www.asx.com.au under the Company’s ASX code “AAR”; or
(c) If you have provided an email address and have elected to receive electronic communications
from the Company, you will receive an email to your nominated email address with a link to an
electronic copy of the Meeting materials and the voting instruction form.
A copy of the Proxy Form is enclosed for convenience.
The Company intends to hold a physical meeting. The Company will notify any changes to this by way
of an announcement on ASX and the details will also be made available on the Company’s website.
The Meeting materials are important and should be read in their entirety. If you are in doubt as to the
course of action you should follow, you should consult your stock broker, investment advisor,
accountant, solicitor or other professional adviser.
Yours sincerely
Brendon Morton
Company Secretary
ASTRAL RESOURCES NL
(ACN 009 159 077)
NOTICE OF GENERAL MEETING
The General Meeting of the Company will be held at the Conference Centre,
Ground Floor, Central Park Tower, 152-158 St Georges Terrace, Perth
Western Australia 6000 on Monday, 20 May 2024 at 10:00am (AWST).
Shareholders are encouraged to submit any questions in advance of the Meeting by emailing the
questions to meetings@astralresources.com.au by no later than 5:00pm (AWST) 17 May 2024.
Shareholders are also strongly encouraged to lodge their completed proxy forms in accordance with
the instructions in this Notice of Meeting.
If the above arrangements with respect to the Meeting change, Shareholders will be updated via the
ASX
Market
Announcements
Platform
and
on
the
Company’s
website
at
www.astralresources.com.au.
This Notice and the accompanying Explanatory Memorandum should be read in full. If Shareholders
are in doubt as to how they should vote, they should seek advice from their stockbroker, investment
advisor, accountant, solicitor or other professional adviser prior to voting.
Should you wish to discuss any matter please do not hesitate to contact the Company
Secretary by telephone on (08) 9382 8822.
IMPORTANT INFORMATION
TIME AND PLACE OF MEETING
Notice is hereby given that the general meeting of shareholders of Astral Resources NL (ACN 009 159
077) (Company) will be held at the Conference Centre, Ground Floor, Central Park Tower, 152-158 St
Georges Terrace, Perth Western Australia 6000 on Monday, 20 May 2024 at 10:00am (AWST)
(Meeting).
This Notice is being made available to Shareholders electronically and can be viewed and downloaded
online from the Company’s website at www.astralresources.com.au.
Instructions on how to attend the Meeting and vote are in the Explanatory Memorandum. The
Explanatory Memorandum and the Proxy Form form part of this Notice.
Terms and abbreviations used in this Notice (including the Explanatory Memorandum) are defined in
Schedule 1.
YOUR VOTE IS IMPORTANT
The business of the Meeting affects your shareholding and your vote is important.
VOTING ELIGIBILITY
The Directors have determined pursuant to regulations 7.11.37 and 7.11.38 of the Corporations
Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered as
Shareholders on Saturday, 18 May 2024 at 10:00am (AWST).
BUSINESS OF THE MEETING
AGENDA
1
Resolution 1 – Ratify the Issue of Placement Shares
under Listing Rule 7.1
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution
the following:
"That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the prior issue of 89,959,943 Shares at an issue price of $0.05 per Share
to the Placement Participants pursuant to the Placement under Listing Rule 7.1 on the terms
and conditions in the Explanatory Memorandum."
Voting Exclusion
The Company will disregard any votes cast in favour of the Resolution by or on behalf of a
person who participated in the Placement or an associate of that person (or those persons).
However, this does not apply to a vote cast in favour of this Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution,
in accordance with directions given to the proxy or attorney to vote on this Resolution
in that way; or
2
(b)
the Chairperson as proxy or attorney for a person who is entitled to vote on this
Resolution, in accordance with a direction given to the Chairperson to vote on this
Resolution as the Chairperson decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Resolution 2 – Ratify the Issue of Placement Shares
under Listing Rule 7.1A
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution
the following:
"That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the prior issue of 50,040,057 Shares at an issue price of $0.05 per Share
to Placement Participants pursuant to the Placement under Listing Rule 7.1A on the terms
and conditions in the Explanatory Memorandum."
Voting Exclusion
The Company will disregard any votes cast in favour of the Resolution by or on behalf of a
person who participated in the Placement or an associate of that person (or those persons).
However, this does not apply to a vote cast in favour of this Resolution by:
3
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution,
in accordance with directions given to the proxy or attorney to vote on this Resolution
in that way; or
(b)
the Chairperson as proxy or attorney for a person who is entitled to vote on this
Resolution, in accordance with a direction given to the Chairperson to vote on this
Resolution as the Chairperson decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Resolution 3 – Ratify the Issue of Broker Options to
Joint Lead Managers
To consider and, if thought fit, to pass with or without amendment, as an ordinary resolution
the following:
"That, pursuant to and in accordance with Listing Rule 7.4 and for all other purposes,
Shareholders ratify the issue of 17,000,000 Broker Options to the Joint Lead Managers
(and/or their respective nominee(s)) under Listing Rule 7.1 on the terms and conditions in the
Explanatory Memorandum."
Voting Exclusion
The Company will disregard any votes cast in favour of the Resolution by or on behalf of the
Joint Lead Managers or an associate of those persons.
However, this does not apply to a vote cast in favour of this Resolution by:
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution,
in accordance with directions given to the proxy or attorney to vote on this Resolution
in that way; or
(b)
the Chairperson as proxy or attorney for a person who is entitled to vote on this
Resolution, in accordance with a direction given to the Chairperson to vote on this
Resolution as the Chairperson decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
4
Resolution 4 – Issue of Director Shares to Mr Marc
Ducler
To consider and, if thought fit, to pass with or without amendment, the following resolution as
an ordinary resolution:
"That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes,
Shareholders approve the issue of 1,600,000 Shares at an issue price of $0.05 per Share to
Mr Marc Ducler (and/or his nominee(s)) on the terms and conditions in the Explanatory
Memorandum.”
Voting Exclusion
The Company will disregard any votes cast in favour of this Resolution by or on behalf of Mr
Marc Ducler (and/or his nominee(s)) and any other person who will obtain a material benefit as
a result of the proposed issue of Shares (except a benefit solely by reason of being a holder of
ordinary securities in the Company) or an associate of that person (or those persons).
However, this does not apply to a vote cast in favour of this Resolution by:
5
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution,
in accordance with directions given to the proxy or attorney to vote on this Resolution
in that way; or
(b)
the Chairperson as proxy or attorney for a person who is entitled to vote on this
Resolution, in accordance with a direction given to the Chairperson to vote on this
Resolution as the Chairperson decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Resolution 5 – Issue of Director Shares to Mr David
Varcoe
To consider and, if thought fit, to pass with or without amendment, the following resolution as
an ordinary resolution:
"That, pursuant to and in accordance with Listing Rule 10.11 and for all other purposes,
Shareholders approve the issue of 500,000 Shares at an issue price of $0.05 per Share to Mr
David Varcoe (and/or his nominee(s)) on the terms and conditions in the Explanatory
Memorandum.”
Voting Exclusion
The Company will disregard any votes cast in favour of this Resolution by or on behalf of Mr
David Varcoe (and/or his nominee(s)) and any other person who will obtain a material benefit
as a result of the proposed issue of Shares (except a benefit solely by reason of being a holder
of ordinary securities in the Company) or an associate of that person (or those persons).
However, this does not apply to a vote cast in favour of this Resolution by:
6
(a)
a person as proxy or attorney for a person who is entitled to vote on this Resolution,
in accordance with directions given to the proxy or attorney to vote on this Resolution
in that way; or
(b)
the Chairperson as proxy or attorney for a person who is entitled to vote on this
Resolution, in accordance with a direction given to the Chairperson to vote on this
Resolution as the Chairperson decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on
behalf of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary
is not excluded from voting and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Resolution 6 – Election of Mark Connelly as Director
To consider and, if thought fit, to pass as an ordinary resolution:
"That, Mr Mark Connelly, who was appointed as a Director on 27 December 2023 retires in
accordance with article 7.3(c) of the Constitution and is eligible for re-election, is elected as a
Director."
Dated: 15 April 2024
By order of the Board
Brendon Morton
Company Secretary
ASTRAL RESOURCES NL
ACN 009 159 077
EXPLANATORY MEMORANDUM
1
Introduction
This Explanatory Memorandum has been prepared for the information of Shareholders in
connection with the business to be conducted at the Meeting. It should be read in conjunction
with, and forms part of, the Notice.
This Explanatory Memorandum includes the following information to assist Shareholders in
deciding how to vote on the Resolutions:
Section 2
Action to be taken by Shareholders
Section 3
Background to Placement
Section 4
Resolution 1 – Ratify the issue of Placement Shares under Listing Rule
7.1
Section 6
Resolution 2 – Ratify the issue of Placement Shares under Listing Rule
7.1A
Section 6
Resolution 3 – Ratify the issue of Broker Options to Joint Lead Managers
Section 7
Resolutions 4 and 5 – Issue of Shares to Messrs Marc Ducler and David
Varcoe
Section 8
Resolution 6 – Election of Mark Connelly as Director
Schedule 1
Definitions and Interpretation
Schedule 2
Terms and Conditions of Broker Options
A Proxy Form is located at the end of this Explanatory Memorandum.
2
Action to be taken by Shareholders
Shareholders should read this Notice (including this Explanatory Memorandum) carefully before
deciding how to vote on the Resolutions.
2.1
Proxies
A Proxy Form is attached to this Notice. This is to be used by Shareholders if they wish to
appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and
encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the
Proxy Form to the Company in accordance with the instructions set out in the Proxy Form.
Returning the Proxy Form to the Company will not preclude a Shareholder from attending or
(subject to the voting exclusions set out in this Notice) voting at the Meeting in person.
Please note that:
(a)
a Shareholder entitled to attend and vote at the Meeting is entitled to appoint a proxy;
(b)
a proxy need not be a Shareholder; and
(c)
a Shareholder entitled to cast two or more votes may appoint two proxies and may
specify the proportion or number of votes each proxy is appointed to exercise. Where
the proportion or number is not specified, each proxy may exercise half of the votes.
To vote by proxy:
(a)
Please load the Proxy Form online at https://investor.automic.com.au/#/loginsh by
following the instructions below:
Login to the Automic website using the holding details as shown as the Proxy Form.
Click on ‘Meetings – Vote’. To use the online lodgement facility, Shareholders will need
their holder number (Securityholder Reference Number (SRN) or Holder Identification
Number (HIN)) as shown on the front of the Proxy Form; or
(b)
Please complete and sign the enclosed Proxy Form and return by the time and in
accordance with the instructions set out on the Proxy Form.
Proxy Forms must be received by the Company no later than 10:00am (AWST) on 18 May
2024, being at least 48 hours before the Meeting. The Proxy Form provides further details on
appointing proxies and lodging Proxy Forms.
2.2
Attendance at the Meeting
The Company encourages all Shareholders to vote by directed proxy. Proxy forms for the
meeting should be lodged before 10:00am (AWST) on 18 May 2024.
Shareholders are encouraged to submit any questions in advance of the Meeting by emailing
the questions to meetings@astralresources.com.au by no later than 5:00pm] (AWST) on 17
May 2024.
If the above arrangements with respect to the Meeting change, Shareholders will be updated
via the ASX Market Announcements Platform and on the Company’s website at
www.astralresources.com.au.
3
Background to Placement
On 28 March 2024, the Company announced a placement of 140 million new fully paid
ordinary Shares in the Company (Placement Shares) at an issue price of A$0.05 per Share
to raise approximately $7 million (Placement).
The Placement offers were made to institutional, professional and sophisticated investors in
Australia, New Zealand, Singapore, Hong Kong and the United Kingdom (Placement
Participants).
Euroz Hartleys and Cumulus Wealth Pty Ltd acted as joint lead managers to the Placement
(Joint Lead Managers).
The Placement Shares were issued pursuant to the Company's existing placement capacity
under Listing Rule 7.1 and Listing Rule 7.1A.
Proceeds from the Placement will be applied towards:
(a)
diamond and RC drilling, assays and testwork at Mandilla and Feysville gold projects
(Projects);
(b)
Mineral Resource Estimate updates for the Projects;
(c)
exploration and evaluation support or overheads;
(d)
the undertaking of a pre-feasibility study; and
(e)
general working capital purposes.
4
Resolution 1 – Ratify the issue of Placement Shares
under Listing Rule 7.1
4.1
General
Refer to Section 3 for further details on the Placement.
The Placement Shares were issued on 9 April 2024. The Placement Shares comprised:
(a)
89,959,943 Shares issued under the Company's Listing Rule 7.1 capacity (LR 7.1
Placement Shares); and
(b)
50,040,057 Shares issued under the Company's Listing Rule 7.1A capacity (LR
7.1A Placement Shares).
Resolution 1 seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the prior issue
of Placement Shares issued under Listing Rule 7.1.
Resolution 1 is an ordinary resolution.
The Chairperson intends to exercise all available proxies in favour of Resolution 1.
4.2
Listing Rule 7.1
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of
securities that a listed company can issue without the approval of its shareholders over any
12-month period to 15% of the fully paid period securities it had on issue at the start of that
period.
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of Equity
Securities after it has been made or agreed to be made. Following shareholder approval, the
issue is taken to have been approved under Listing Rule 7.1 (and provided that the prior issue
did not breach Listing Rule 7.1) and the issue does not reduce the company's capacity to
issue further Equity Securities without shareholder approval under the rule.
The Company wishes to retain as much flexibility as possible to issue additional Equity
Securities in the future without having to obtain Shareholder approval.
If Resolution 1 is passed, the issue of the LR 7.1 Placement Shares will be excluded in the
calculation of the Company's 15% limit under Listing Rule 7.1, effectively increasing the
number of Equity Securities the Company can issue without Shareholder approval over the
12-month period following the issue date.
If Resolution 1 is not passed, the issue of the LR 7.1 Placement Shares will be included in the
calculation of the Company's 15% limit under Listing Rule 7.1, effectively decreasing the
number of Equity Securities the Company can issue without Shareholder approval over the
12-month period following the issue date.
4.3
Specific information required by Listing Rule 7.5
In accordance with Listing Rule 7.5, the following information is provided to the issue of the
Placement Shares:
(a)
89,959,943 Placement Shares were issued to institutional, professional and
sophisticated investors identified by the Joint Lead Managers through bookbuild
processes. None of the Placement Participants are related parties or associates of
related parties of the Company;
4.4
(b)
89,959,943 Shares were issued pursuant to Listing Rule 7.1, ratification of which is
sought pursuant to Resolution 1;
(c)
the Placement Shares are fully paid ordinary Shares in the Company and rank
equally in all respects with the Company's existing Shares on issue;
(d)
the 89,959,943 Placement Shares were issued at $0.05 per Share, raising
approximately $4.5 million;
(e)
the Placement Shares were issued on 9 April 2024;
(f)
proceeds of approximately $7 million were received from the issue of the
Placement Shares, which will be applied towards the advancement of the
Company's Mandilla and Feysville Gold Projects as detailed in Section 3;
(g)
the Placement Shares were issued under placement letters pursuant to which
subscribers to the Placement Participants received Shares at an issue price of
$0.05 per Share;
(h)
Euroz Hartleys and Cumulus acted as joint lead managers to the Placement; and
(i)
a voting exclusion statement is included in the Notice for Resolution 1.
Directors Recommendation
The Directors recommend that Shareholders vote in favour of Resolution 1.
5
Resolution 2 – Ratify the issue of Placement Shares
under Listing Rule 7.1A
5.1
General
Refer to Section 3 for further details on the Placement.
Resolution 2 seeks Shareholder approval pursuant to Listing Rule 7.4 for the prior issue of
Placement Shares under Listing Rule 7.1A.
Resolution 2 is an ordinary resolution.
The Chairperson intends to exercise all available proxies in favour of Resolution 2.
5.2
Listing Rule 7.1A
Listing Rule 7.1A enables an eligible entity to issue Equity Securities up to 10% of its issued
share capital through placements over a 12-month period after the annual general meeting
(10% Placement Facility). The 10% Placement Facility is additional to a company's 15%
annual placement capacity under Listing Rule 7.1. The Company obtained the requisite
shareholder approval under Listing Rule 7.1A at its 2023 annual general meeting.
Listing Rule 7.4 provides that where a company in general meeting ratifies the prior issue of
securities made pursuant to Listing Rule 7.1A (and provided that the prior issue of those
securities did not breach Listing Rule 7.1A), those securities will be deemed to have been
made with Shareholder approval for the purpose of Listing Rule 7.1A. The Company confirms
that the issue of 7.1A Placement Shares under the Placement did not breach Listing Rule
7.1A.
The Company wishes to retain as much flexibility as possible to issue additional Equity
Securities into the future without having to obtain Shareholder approval for issues under
Listing Rule 7.1A.
If Resolution 2 is passed, the issue of the LR 7.1A Placement Shares (as defined in Section
4.1) will be excluded in calculating the Company's 10% limit in Listing Rule 7.1A, effectively
increasing the number of Equity Securities the Company can issue without Shareholder
approval over the 12-month period after the annual general meeting.
If Resolution 2 is not passed, the issue of the LR 7.1A Placement Shares will be included in
calculating the Company's 10% limit in Listing Rule 7.1A, effectively decreasing the number of
Equity Securities the Company can issue without Shareholder approval over the 12-month
period after the annual general meeting.
5.3
Specific information required by Listing Rule 7.5
In accordance with Listing Rule 7.5, the following information is provided to the issue of the
Placement Shares:
5.4
(a)
50,040,057 Placement Shares were issued to institutional, professional and
sophisticated investors identified by the Joint Lead Managers through bookbuild
processes. None of the Placement Participants are related parties or associates of
related parties of the Company;
(b)
50,040,057 Shares were issued pursuant to Listing Rule 7.1A, ratification of which
is sought pursuant to Resolution 2;
(c)
the Placement Shares are fully paid ordinary Shares in the Company and rank
equally in all respects with the Company's existing Shares on issue;
(d)
the 50,040,057 Placement Shares were issued at $0.05 per Share, raising
approximately $2.5 million;
(e)
the Placement Shares were issued on 9 April 2024;
(f)
proceeds of approximately $7 million were received from the issue of the
Placement Shares, which will be applied towards the advancement of the
Company's Mandilla and Feysville Gold Projects as detailed in Section 3;
(g)
the Placement Shares were issued under placement letters pursuant to which
subscribers to the Placement Participants received Shares at an issue price of
$0.05 per Share;
(h)
Euroz Hartleys and Cumulus acted as joint lead managers to the Placement; and
(i)
a voting exclusion statement is included in the Notice for Resolution 2.
Directors Recommendation
The Directors recommend that Shareholders vote in favour of Resolution 2.
6
Resolution 3 – Ratify the issue of Broker Options to
Joint Lead Managers
6.1
General
Euroz Hartleys and Cumulus acted as Joint Lead Managers to the Placement. See Section 3
for further details of the Placement.
Resolution 3 seeks Shareholder approval pursuant to Listing Rule 7.4 to ratify the issue of
17,000,000 Options to the Joint Lead Managers (and/or their respective nominee(s)) in
consideration for the services provided by the Joint Lead Managers in relation to the
Placement (Broker Options).
Resolution 3 is an ordinary resolution.
The Chairperson intends to exercise all available proxies in favour of Resolution 3.
6.2
Listing Rule 7.1
See Section 4.2 for a summary of Listing Rule 7.1 and Listing Rule 7.4.
The Company wishes to retain as much flexibility as possible to issue additional Equity
Securities into the future without having to obtain Shareholder approval for such issues under
Listing Rule 7.1.
If Resolution 3 is passed, the issue of Broker Options will be excluded in calculating the
Company's 15% Placement Capacity in Listing Rule 7.1, effectively increasing the number of
Equity Securities the Company can issue without Shareholder approval over the 12-month
period following the issue of Broker Options.
If Resolution 3 is not passed, the issue of Broker Options will be included in calculating the
Company's 15% Placement Capacity in Listing Rule 7.1, effectively decreasing the number of
Equity Securities the Company can issue without Shareholder approval over the 12-month
period following the issue of Broker Options.
6.3
Specific information required by Listing Rule 7.5
The following information in relation to Resolution 3 is provided to Shareholders for the
purposes of Listing Rule 7.5:
6.4
(a)
17,000,000 Broker Options were issued to Euroz Hartleys and Cumulus (and/or
their respective nominee(s)) on 9 April 2024 as consideration for services provided
by them as Joint Lead Managers to the Placement, utilising the Company's
existing 15% Placement Capacity;
(b)
the 17,000,000 Broker Options have an exercise price of $0.075 and will expire
three (3) years from the date of issue. The terms and conditions of the Broker
Options are detailed in Schedule 2;
(c)
the Shares to be issued on exercise of the Broker Options will be fully paid
ordinary shares in the capital of the Company and will rank equally in all respects
with the Company's existing Shares on issue;
(d)
the Broker Options were issued to the Joint Lead Managers on 9 April 2024;
(e)
the Broker Options were issued for nil cash consideration and no funds were
raised. The Broker Options were issued as part of the fee arrangements for the
provision of lead manager services to the Company in relation to the Placement.
Any funds raised form the exercise of the Broker options will be applied towards
the advancement of the Company's Mandilla and Feysville Gold Projects as
detailed in Section 3;
(f)
the Company entered into a joint lead manager mandate with Euroz Hartleys and
Cumulus pursuant to which Euroz Hartleys and Cumulus agreed to act as Joint
Lead Managers to the Placement. The Company has agreed to pay a fee of 6% of
the funds raised from the Placement and issue of the Broker Options; and
(g)
a voting exclusion statement is included in the Notice for Resolution 3.
Directors Recommendation
The Directors recommend that Shareholders vote in favour of Resolution 3.
7
Resolutions 4 and 5 – Issue of Director Shares to
Messrs Marc Ducler and David Varcoe
7.1
General
On 28 March 2024, the Company announced that the Directors (namely Messrs Marc Ducler
and David Varcoe) subscribed for an additional 2.1 million Shares (Director Shares) on the
same terms as the Placement. The issue of Director Shares to Messrs Ducler and Varcoe is
subject to Shareholder approval pursuant to Resolutions 4 and 5.
Resolution 4 seeks Shareholder approval pursuant to Listing Rule 10.11 for the issue of
1,600,000 Director Shares at an issue price of $0.05 per Share to Mr Marc Ducler (and/or his
respective nominee(s)).
Resolution 5 seeks Shareholder approval pursuant to Listing Rule 10.11 for the issue of
500,000 Director Shares at an issue price of $0.05 per Share to Mr David Varcoe (and/or his
respective nominee(s)).
Resolutions 4 and 5 are ordinary resolutions.
The Chairperson intends to exercise all available proxies in favour of Resolutions 4 and 5.
7.2
Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company
Share your feedback
Discover